Incline Therapeutics Raises $43 Million, Signs Acquisition Option
Posted on: June 22, 2010 by PEHub AdministratorNo Comments »
Incline Therapeutics Inc., a hospital-focused specialty pharma startup, has raised $43 million in Series A funding. Frazier Healthcare Ventures led the round, and was joined by 5AM Ventures, Technology Partners, Adams Street Partners, Saints Capital Partners and Emergent Medical Partners. Also receiving shares was Cadence Pharmaceuticals Inc. (Nasdaq: CADX), which signed an option to acquire Incline for up to $285 million.
In related news, Incline agreed to acquire the global rights to IONSYS, patient-controlled analgesia for adult inpatients requiring opioids following surgery, from ALZA Corp.



